@article{article, title  = {{Adjusting for the Confounding Effects of Treatment Switching—The BREAK‐3 Trial: Dabrafenib Versus Dacarbazine}},

 publisher = {{Wiley}},

 url = {{}},

 year = {{2015}},

 month = {{6}},

 author = {{Latimer NR and Abrams KR and Amonkar MM and Stapelkamp C and Swann RS}},

 doi = {{10.1634/theoncologist.2014-0429}},

 volume = {{20}},

 journal = {{The Oncologist}},

 issue = {{7}},

 pages = {{798-805}},

 note = {{Accessed on 2024/12/22}}}